WEKO3
アイテム
{"_buckets": {"deposit": "d1d180c4-3c12-40af-bf14-17ce055f3dc4"}, "_deposit": {"created_by": 1, "id": "83871", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "83871"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00083871", "sets": ["28"]}, "author_link": ["1012159", "1012160", "1012158", "1012157", "1012156", "1012161", "1012154", "1012155"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2021-06-04", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The QST hospital has successfully treated more than 200 patients with choroidal melanoma by broad beam carbon ion radiotherapy (CIRT) with a compensator and a patient-specific collimator since 2001. We decided in 2017 to use scanning carbon ion beam with a rotating gantry for this treatment owing to its flexibilities of dose conformation and beam direction, and then its clinical trial started in April, 2018.\nIn our facility, a commercial 2D ionization chamber array had been employed to verify the 2D dose distribution for any patient specific QA. [1] However, the target volume in choroidal melanoma treatment is typically so small that the 2D array is not appropriate to the verification tool of 2D dose distribution due to its low spatial resolution. Thus, in this clinical trial, we applied new method to the patient specific QA. The method consists of two dosimetric verifications by measurements of depth dose distribution with the Bragg peak chamber and lateral dose distributions at three different depths with the pinpoint chambers, and a verification of beam position at each beam spot with the existing beam position monitor (multi-wire proportional chamber). This method was successfully applied to patient specific QAs for 44 treatment beams of all 22 patients received scanning CIRT for choroidal melanoma in this clinical trial until July, 2019. Here, we provide the summary of the QA results and introduce the current QA procedure based on this clinical trial.\n [1] T. Furukawa et al., Med. Phys., 40, 121707 (2013).\n", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "The 59th Annual Conference of the Particle Therapy Co-Operative Group (PTCOG59)", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Shunsuke, Yonai"}], "nameIdentifiers": [{"nameIdentifier": "1012154", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Naoya, Saotome"}], "nameIdentifiers": [{"nameIdentifier": "1012155", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Makoto, Sakama"}], "nameIdentifiers": [{"nameIdentifier": "1012156", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nobuyuki, Kanematsu"}], "nameIdentifiers": [{"nameIdentifier": "1012157", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shunsuke, Yonai", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1012158", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Naoya, Saotome", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1012159", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Makoto, Sakama", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1012160", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nobuyuki, Kanematsu", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1012161", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Patient specific QA of scanning beam carbon ion radiotherapy with rotating gantry for choroidal melanoma in clinical trial", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Patient specific QA of scanning beam carbon ion radiotherapy with rotating gantry for choroidal melanoma in clinical trial"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/83871", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-11-22"}, "publish_date": "2021-11-22", "publish_status": "0", "recid": "83871", "relation": {}, "relation_version_is_last": true, "title": ["Patient specific QA of scanning beam carbon ion radiotherapy with rotating gantry for choroidal melanoma in clinical trial"], "weko_shared_id": -1}
Patient specific QA of scanning beam carbon ion radiotherapy with rotating gantry for choroidal melanoma in clinical trial
https://repo.qst.go.jp/records/83871
https://repo.qst.go.jp/records/838714f89b8c3-f63a-4061-98ce-d72f15c2951e
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-11-22 | |||||
タイトル | ||||||
タイトル | Patient specific QA of scanning beam carbon ion radiotherapy with rotating gantry for choroidal melanoma in clinical trial | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Shunsuke, Yonai
× Shunsuke, Yonai× Naoya, Saotome× Makoto, Sakama× Nobuyuki, Kanematsu× Shunsuke, Yonai× Naoya, Saotome× Makoto, Sakama× Nobuyuki, Kanematsu |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The QST hospital has successfully treated more than 200 patients with choroidal melanoma by broad beam carbon ion radiotherapy (CIRT) with a compensator and a patient-specific collimator since 2001. We decided in 2017 to use scanning carbon ion beam with a rotating gantry for this treatment owing to its flexibilities of dose conformation and beam direction, and then its clinical trial started in April, 2018. In our facility, a commercial 2D ionization chamber array had been employed to verify the 2D dose distribution for any patient specific QA. [1] However, the target volume in choroidal melanoma treatment is typically so small that the 2D array is not appropriate to the verification tool of 2D dose distribution due to its low spatial resolution. Thus, in this clinical trial, we applied new method to the patient specific QA. The method consists of two dosimetric verifications by measurements of depth dose distribution with the Bragg peak chamber and lateral dose distributions at three different depths with the pinpoint chambers, and a verification of beam position at each beam spot with the existing beam position monitor (multi-wire proportional chamber). This method was successfully applied to patient specific QAs for 44 treatment beams of all 22 patients received scanning CIRT for choroidal melanoma in this clinical trial until July, 2019. Here, we provide the summary of the QA results and introduce the current QA procedure based on this clinical trial. [1] T. Furukawa et al., Med. Phys., 40, 121707 (2013). |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | The 59th Annual Conference of the Particle Therapy Co-Operative Group (PTCOG59) | |||||
発表年月日 | ||||||
日付 | 2021-06-04 | |||||
日付タイプ | Issued |